CAD 0.12
(4.35%)
Year | Eps | Eps Growth |
---|---|---|
2023 | -0.05 CAD | 95.73% |
2022 | -0.12 CAD | 25.63% |
2021 | -0.15 CAD | 0.0% |
2020 | -1.60 CAD | -1.91% |
2019 | -0.11 CAD | -4064.46% |
2018 | -0.04 CAD | -5.01% |
2017 | -0.04 CAD | -7080.0% |
2016 | -0.00 CAD | 97.76% |
2015 | -0.00 CAD | 0.0% |
Year | Eps | Eps Growth |
---|---|---|
2024 Q2 | -0.01 CAD | -1.57% |
2024 Q1 | -0.01 CAD | -2.42% |
2024 Q3 | -0.01 CAD | 43.41% |
2023 Q4 | -0.01 CAD | 22.98% |
2023 FY | - CAD | 95.73% |
2023 Q1 | -0.01 CAD | 88.31% |
2023 Q3 | -0.02 CAD | -163.93% |
2023 Q2 | -0.01 CAD | 46.96% |
2022 Q4 | -0.10 CAD | -430.2% |
2022 FY | - CAD | 25.63% |
2022 Q3 | 0.03 CAD | 263.74% |
2022 Q2 | -0.02 CAD | 43.65% |
2022 Q1 | -0.03 CAD | -1.89% |
2021 Q1 | -0.06 CAD | 12.02% |
2021 Q2 | -0.04 CAD | 25.5% |
2021 Q3 | -0.03 CAD | 29.53% |
2021 Q4 | -0.03 CAD | -0.63% |
2021 FY | - CAD | 0.0% |
2020 Q2 | -0.01 CAD | -1.69% |
2020 FY | - CAD | -1.91% |
2020 Q4 | -0.07 CAD | -264.71% |
2020 Q3 | -0.02 CAD | -211.67% |
2020 Q1 | -0.01 CAD | 28.05% |
2019 Q4 | -0.01 CAD | -173.33% |
2019 Q3 | -0.00 CAD | 58.33% |
2019 Q2 | -0.01 CAD | 45.45% |
2019 FY | - CAD | -4064.46% |
2019 Q1 | -0.01 CAD | 8.97% |
2018 Q1 | -0.02 CAD | -28.47% |
2018 FY | - CAD | -5.01% |
2018 Q4 | -0.01 CAD | -51.04% |
2018 Q3 | -0.01 CAD | -260.0% |
2018 Q2 | 0.01 CAD | 134.09% |
2017 Q2 | 0.00 CAD | 0.0% |
2017 Q3 | -0.01 CAD | -2400.0% |
2017 Q4 | -0.01 CAD | -98.55% |
2017 FY | - CAD | -7080.0% |
2016 FY | - CAD | 97.76% |
2015 FY | - CAD | 0.0% |
Name | Eps | Eps Difference |
---|---|---|
Algernon Pharmaceuticals Inc. | -0.45 CAD | 88.711% |
Asep Medical Holdings Inc | -0.13 CAD | 60.923% |
BetterLife Pharma Inc. | -0.03 CAD | -92.424% |
BioVaxys Technology Corp. | -0.06 CAD | 11.344% |
ChitogenX Inc. | -0.02 CAD | -138.498% |
Rapid Dose Therapeutics Corp. | -0.04 CAD | -23.902% |
Defence Therapeutics Inc. | -0.30 CAD | 83.067% |
Gemina Laboratories Ltd. | -0.07 CAD | 29.444% |
Glow Lifetech Corp. | -0.03 CAD | -76.389% |
Lexston Life Sciences Corp. | -0.02 CAD | -120.87% |
Pharmala Biotech Holdings Inc. | -0.01 CAD | -452.174% |
Doseology Sciences Inc. | -0.08 CAD | 36.261% |
MYND Life Sciences Inc. | -0.03 CAD | -58.255% |
Nova Mentis Life Science Corp. | -0.01 CAD | -512.048% |
PharmaTher Holdings Ltd. | -0.04 CAD | -43.909% |
PreveCeutical Medical Inc. | -0.00 CAD | -2016.667% |
Telescope Innovations Corp. | -0.12 CAD | 57.667% |